FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2083478110> ?p ?o ?g. }

• W2083478110 endingPage "419" @default.
• W2083478110 startingPage "415" @default.
• W2083478110 abstract "We describe 2 elderly patients with Human herpesvirus 8 (HHV-8)/Kaposi sarcoma herpes virus negative malignant effusion lymphoma showing pan-B-cell immunophenotyping markers and successfully treated with a chimeric anti-CD20 IgG1 monoclonal antibody, rituximab. A 90-year-old man and an 87-year-old woman were hospitalized because of pleural effusions. They were diagnosed as having malignant effusion lymphoma on the basis of cytologic and flow cytometric findings of effusions, revealing involvement of atypical lymphoid cells and expression of CD19 and CD20. The former case was intolerant of chemotherapy because of toxicity. Using the conventional dose of rituximab, they showed neither intolerance nor adverse effects and their pleural effusions decreased immediately. Any sign of disease progression was not noted in either of the patients. They were negative for a HHV-8 infection and had no history of pyothorax. This type of lymphoma was not compatible with primary effusion lymphoma (PEL) defined by World Health Organization Classification of Tumors or pyothorax-associated lymphoma. We diagnosed these patients as having HHV-8 negative malignant effusion lymphoma. HHV-8 negative malignant effusion lymphoma may be a new clinicopathologic and biologic entity. Because most of the cases were positive for pan-B-cell markers, rituximab may be a promising agent for the treatment." @default.
• W2083478110 created "2016-06-24" @default.
• W2083478110 creator A5017078328 @default.
• W2083478110 creator A5019252781 @default.
• W2083478110 creator A5026513889 @default.
• W2083478110 creator A5028457340 @default.
• W2083478110 creator A5047816889 @default.
• W2083478110 creator A5054667160 @default.
• W2083478110 creator A5055153528 @default.
• W2083478110 creator A5089196061 @default.
• W2083478110 creator A5089552154 @default.
• W2083478110 creator A5091651385 @default.
• W2083478110 date "2005-01-01" @default.
• W2083478110 modified "2023-10-16" @default.
• W2083478110 title "Human herpesvirus 8-negative malignant effusion lymphoma: A distinct clinical entity and successful treatment with rituximab" @default.
• W2083478110 cites W2010082953 @default.
• W2083478110 cites W2016625585 @default.
• W2083478110 cites W2018060648 @default.
• W2083478110 cites W2033318086 @default.
• W2083478110 cites W2038068370 @default.
• W2083478110 cites W2047149041 @default.
• W2083478110 cites W2049701184 @default.
• W2083478110 cites W2050454027 @default.
• W2083478110 cites W2065669571 @default.
• W2083478110 cites W2069289044 @default.
• W2083478110 cites W2077626603 @default.
• W2083478110 cites W2132742441 @default.
• W2083478110 cites W2160508776 @default.
• W2083478110 cites W2160582444 @default.
• W2083478110 cites W2413054343 @default.
• W2083478110 cites W4243068141 @default.
• W2083478110 doi "https://doi.org/10.1080/10428190400018364" @default.
• W2083478110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15621832" @default.
• W2083478110 hasPublicationYear "2005" @default.
• W2083478110 type Work @default.
• W2083478110 sameAs 2083478110 @default.
• W2083478110 citedByCount "60" @default.
• W2083478110 countsByYear W20834781102012 @default.
• W2083478110 countsByYear W20834781102013 @default.
• W2083478110 countsByYear W20834781102014 @default.
• W2083478110 countsByYear W20834781102015 @default.
• W2083478110 countsByYear W20834781102016 @default.
• W2083478110 countsByYear W20834781102017 @default.
• W2083478110 countsByYear W20834781102018 @default.
• W2083478110 countsByYear W20834781102019 @default.
• W2083478110 countsByYear W20834781102020 @default.
• W2083478110 countsByYear W20834781102021 @default.
• W2083478110 countsByYear W20834781102022 @default.
• W2083478110 countsByYear W20834781102023 @default.
• W2083478110 crossrefType "journal-article" @default.
• W2083478110 hasAuthorship W2083478110A5017078328 @default.
• W2083478110 hasAuthorship W2083478110A5019252781 @default.
• W2083478110 hasAuthorship W2083478110A5026513889 @default.
• W2083478110 hasAuthorship W2083478110A5028457340 @default.
• W2083478110 hasAuthorship W2083478110A5047816889 @default.
• W2083478110 hasAuthorship W2083478110A5054667160 @default.
• W2083478110 hasAuthorship W2083478110A5055153528 @default.
• W2083478110 hasAuthorship W2083478110A5089196061 @default.
• W2083478110 hasAuthorship W2083478110A5089552154 @default.
• W2083478110 hasAuthorship W2083478110A5091651385 @default.
• W2083478110 hasConcept C126322002 @default.
• W2083478110 hasConcept C141071460 @default.
• W2083478110 hasConcept C142724271 @default.
• W2083478110 hasConcept C147483822 @default.
• W2083478110 hasConcept C163430725 @default.
• W2083478110 hasConcept C18031839 @default.
• W2083478110 hasConcept C196166836 @default.
• W2083478110 hasConcept C203014093 @default.
• W2083478110 hasConcept C2779338263 @default.
• W2083478110 hasConcept C2779594685 @default.
• W2083478110 hasConcept C2779634585 @default.
• W2083478110 hasConcept C2780653079 @default.
• W2083478110 hasConcept C71924100 @default.
• W2083478110 hasConceptScore W2083478110C126322002 @default.
• W2083478110 hasConceptScore W2083478110C141071460 @default.
• W2083478110 hasConceptScore W2083478110C142724271 @default.
• W2083478110 hasConceptScore W2083478110C147483822 @default.
• W2083478110 hasConceptScore W2083478110C163430725 @default.
• W2083478110 hasConceptScore W2083478110C18031839 @default.
• W2083478110 hasConceptScore W2083478110C196166836 @default.
• W2083478110 hasConceptScore W2083478110C203014093 @default.
• W2083478110 hasConceptScore W2083478110C2779338263 @default.
• W2083478110 hasConceptScore W2083478110C2779594685 @default.
• W2083478110 hasConceptScore W2083478110C2779634585 @default.
• W2083478110 hasConceptScore W2083478110C2780653079 @default.
• W2083478110 hasConceptScore W2083478110C71924100 @default.
• W2083478110 hasIssue "3" @default.
• W2083478110 hasLocation W20834781101 @default.
• W2083478110 hasLocation W20834781102 @default.
• W2083478110 hasOpenAccess W2083478110 @default.
• W2083478110 hasPrimaryLocation W20834781101 @default.
• W2083478110 hasRelatedWork W1508574050 @default.
• W2083478110 hasRelatedWork W1964482611 @default.
• W2083478110 hasRelatedWork W1999852381 @default.
• W2083478110 hasRelatedWork W2009214800 @default.
• W2083478110 hasRelatedWork W2027842929 @default.
• W2083478110 hasRelatedWork W2062782061 @default.
• W2083478110 hasRelatedWork W2083478110 @default.

• next